1. Stocks
    2. /
  2. Race Oncology Limited (ASX: RAC)
    3. /

Race Oncology Limited (ASX: RAC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Race Oncology Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Race Oncology Limited (ASX: RAC)
    Latest News

    A health professional wearing green scrubs and a face mask and stethoscope uses his mobile phone.
    Healthcare Shares

    In the green: Here are the 5 best ASX healthcare shares of 2021

    | Zach Bristow

    ASX healthcare shares were a strong bunch last year, with several majors and minors outperforming the primary indices.

    Read more »

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    Here's why the Race Oncology (ASX:RAC) share price is edging higher

    | Aaron Teboneras

    The pharmaceutical company's shares are picking up steam on Tuesday. Here are the details

    Read more »

    A medical specialist holds a red heart connected via technology and artificial intelligence (AI)
    Healthcare Shares

    Here's why the Race Oncology (ASX:RAC) share price is climbing today

    | Monica O'Shea

    Why is Race Oncology making the heart tick today?

    Read more »

    A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
    Healthcare Shares

    Why is the Race Oncology (ASX:RAC) share price plunging 12% today?

    | Zach Bristow

    It hasn't been a good day for the precision oncology company.

    Read more »

    A young woman with tattoos puts both thumbs down and scrunches her face.
    Share Fallers

    Why Bapcor, Mayne Pharma, Race Oncology, and TechnologyOne shares are sinking

    | James Mickleboro

    These ASX shares are falling on Wednesday...

    Read more »

    man jumping along increasing bar graph signifying jump in alumina share price
    Healthcare Shares

    Racing higher: Race Oncology (ASX:RAC) share price jumps 13% on study breakthrough

    | Zach Bristow

    It was a good day for the healthcare company.

    Read more »

    Two laboratory researchers in white coats and gloves sit side by side with scientific equipment and a computer screen conducting medical related research.
    Share Gainers

    Why the Race Oncology (ASX:RAC) share price is up on Monday

    | Zach Bristow

    There's more pipeline momentum out of Race's camp today.

    Read more »

    A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
    Healthcare Shares

    Race Oncology (ASX:RAC) share price struggles despite new Leukemia study

    | Aaron Teboneras

    Race Oncology is progressing with its Zantrene study.

    Read more »

    Three healthcare workers look and point at at medical image
    Healthcare Shares

    Race Oncology (ASX:RAC) share price edges higher amid patent update

    | Zach Bristow

    Race shares have moved into the green after a rollercoaster day so far...

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Share Gainers

    Why the Race Oncology (ASX:RAC) share price is storming higher today

    | James Mickleboro

    The Race Oncology share price is rising again...

    Read more »

    four excited doctors with their hands in the air
    Healthcare Shares

    Why the Race Oncology (ASX:RAC) share price surged 7% today

    | Zach Bristow

    Race Oncology shares shot out of the starting blocks today after positive study results.

    Read more »

    Lab worker puts hands in the air and dances around.
    Share Gainers

    Why is the Race Oncology (ASX:RAC) share price up 18% in a month?

    | Zach Bristow

    Race Oncology shares have been a winner over the last month.

    Read more »

    Frequently Asked Questions

    No, Race Oncology does not pay dividends at this time.

    Sydney-headquartered Race Oncology Ltd listed on the ASX on 13 July 2016.

    RAC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Race Oncology Limited

    Race Oncology Ltd (ASX: RAC) is a clinical-stage global biotechnology company focused on cancer care.

    Race’s lead asset, bisantrene, is a small-molecule anthracene chemotherapeutic. It has demonstrated anti-cancer and cardio-protection effects in 46 clinical trials and around 70 peer-reviewed publications.

    The company is now taking its next-generation bisantrene to new fields of cancer treatment. It is initially focusing on two areas of unmet need: metastatic breast cancer (lead indication) and acute myeloid leukaemia (AML).

    As part of its business strategy and clinical program, Race is also investigating the impact bisantrene and new molecules have on the m6A RNA pathway. This follows independent research describing bisantrene as the most potent inhibitor of fat mass and obesity-associated protein (FTO). Dysregulation of RNA (or the over-expression of FTO) has been shown to be a driver of a diverse range of cancers. Race and its partners are now in pre-clinical studies to explore the synergies and impact of bisantrene on FTO regulation.

    Profile

    since

    Note